<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18655" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Bronchopulmonary Dysplasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sahni</surname>
            <given-names>Mitali</given-names>
          </name>
          <aff>Drexel University College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mowes</surname>
            <given-names>Anja K.</given-names>
          </name>
          <aff>Drexel University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mitali Sahni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anja Mowes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18655.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Bronchopulmonary dysplasia is one of the most common causes of morbidity and mortality in preterm infants. Despite significant advances in preterm infant care over the past few decades, the prevalence of this condition remains high. This activity reviews the pathophysiology, evaluation, and management of bronchopulmonary dysplasia and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of bronchopulmonary dysplasia.</p></list-item><list-item><p>Explain how to diagnose bronchopulmonary dysplasia.</p></list-item><list-item><p>Explain the importance of screening patients with bronchopulmonary dysplasia for complications like pulmonary hypertension.</p></list-item><list-item><p>Explain the importance of improving coordination amongst the interprofessional team to enhance the delivery of care for patients with bronchopulmonary dysplasia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18655&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18655">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18655.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The term &#x02018;bronchopulmonary dysplasia&#x02019; (BPD) was first used by Northway et al. in 1967 to describe a chronic form of injury to the lungs caused by barotrauma and oxygen injury in preterm infants requiring mechanical ventilation.<xref ref-type="bibr" rid="article-18655.r1">[1]</xref> Despite significant advances in preterm infant care in the past few decades, including the development of surfactant as well as newer and gentler modes of ventilation, the prevalence of BPD continues to remain high. These new strategies have allowed the survival of very low birth weight infants and resulted in a change in the characteristics of BPD. Jobe coined the term &#x0201c;new BPD&#x0201d; in 1999 to describe the chronic lung disease in preterm infants at that time. This &#x0201c;new BPD&#x0201d; demonstrated much less airway damage and alveolar septal fibrosis when compared to &#x0201c;old BPD&#x0201d; which was characterized by dysmorphic microvasculature and alveolar simplification.<xref ref-type="bibr" rid="article-18655.r2">[2]</xref></p>
      </sec>
      <sec id="article-18655.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Bronchopulmonary dysplasia is a multifactorial pathology that is influenced by a variety of prenatal and postnatal factors affecting the mother and infant. The various prenatal risk factors that influence the development of BPD include<xref ref-type="bibr" rid="article-18655.r3">[3]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Lack of antenatal steroids</p>
          </list-item>
          <list-item>
            <p>Maternal smoking</p>
          </list-item>
          <list-item>
            <p>Pregnancy-induced hypertension/preeclampsia</p>
          </list-item>
          <list-item>
            <p>Hypoxia</p>
          </list-item>
          <list-item>
            <p>Maternal infection, including chorioamnionitis</p>
          </list-item>
          <list-item>
            <p>Genetic susceptibility</p>
          </list-item>
          <list-item>
            <p>Congenital anomalies causing pulmonary hypoplasia</p>
          </list-item>
        </list>
        <p>Similarly, various postnatal factors predispose premature infants to develop BPD including:</p>
        <list list-type="order">
          <list-item>
            <p>Lung immaturity</p>
          </list-item>
          <list-item>
            <p>Poor nutrition</p>
          </list-item>
          <list-item>
            <p>Need for mechanical ventilation</p>
          </list-item>
          <list-item>
            <p>Oxygen injury</p>
          </list-item>
          <list-item>
            <p>Infection/sepsis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18655.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of BPD varies significantly between different centers because of variation in perinatal practices, differences in management styles and lack of consistent definition of BPD. The highest observed rate of BPD is in infants born at a lower gestational age (GA) and lower birth weight.<xref ref-type="bibr" rid="article-18655.r4">[4]</xref>&#x000a0; The data from the neonatal research network reports the incidence of BPD in very low birth weight infants (birth weight less than 1500 grams) to be 40 to 68% depending on the definition of BPD used. This incidence was found to be inversely proportional to the GA of the infant<xref ref-type="bibr" rid="article-18655.r5">[5]</xref> The other demographic risk factors associated with BPD include male sex, low birth weight, white race, impaired growth for GA and family history of asthma.<xref ref-type="bibr" rid="article-18655.r4">[4]</xref></p>
      </sec>
      <sec id="article-18655.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Injury from mechanical ventilation and reactive oxygen species to premature lungs in the presence of antenatal factors predisposing the lungs to BPD form the basis of pathogenesis of BPD in preterm neonates. This myriad of events leads to an exaggerated inflammatory response with an increase in proinflammatory cytokines like interleukin(IL)-6, IL 8, tumor necrosis factor alpha etc along with growth factors (transforming growth factor ) and angiogenic factors (vascular endothelial growth factor, angiopoietin 2) which ultimately results in aberrant tissue repair and arrest in lung development. Dysregulated vascular and arrested alveolar development form the basis of the pathology seen in &#x0201c;new BPD.&#x0201d;<xref ref-type="bibr" rid="article-18655.r6">[6]</xref></p>
      </sec>
      <sec id="article-18655.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Bronchopulmonary dysplasia occurs when lung development arrests in the late canalicular to saccular stages of lung development. The pathology in BPD characteristically demonstrates decreased septation and alveolar hypoplasia resulting in simplified large alveoli and reduced area available for gaseous exchange. There is also dysregulated vasculature with smooth muscle hyperplasia in pulmonary vessels and abnormal alveolar capillaries. Additionally, there is also the presence of increased interstitial fibroproliferation and alveolar septation.<xref ref-type="bibr" rid="article-18655.r7">[7]</xref></p>
      </sec>
      <sec id="article-18655.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical phenotype of infants with BPD is very variable. Depending on the severity of their disease they may or may not need respiratory support. Some may be tachypneic and depending on the degree of pulmonary edema may have signs of respiratory distress like retractions, rales and increased work of breathing.</p>
      </sec>
      <sec id="article-18655.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of BPD involves assessment of blood gas, chest x-ray and evaluating the nutritional status of the patient. An arterial blood gas may reveal hypoxia, hypercarbia or acidosis. These patients remain on continuous pulse oximetry to help target adequate oxygen saturation. Many centers also utilize transcutaneous carbon dioxide monitoring to evaluate the ventilation&#x000a0;of the infant.</p>
        <p>Chest radiographs may&#x000a0;show decreased lung volumes, hyperinflation,&#x000a0;areas of atelectasis, pulmonary edema, and pulmonary interstitial emphysema. High-resolution CT may demonstrate abnormalities not readily seen with routine chest radiography. Infants with moderate or severe BPD must be screened for pulmonary hypertension(PH) at 36 PMA using an echocardiogram. Some centers chose to screen all patients with BPD since the morbidity and mortality associated with&#x000a0;the&#x000a0;diagnosis of PH in BPD are quite high.</p>
        <p>The diagnosis of BPD is made clinically based on the GA, postmenstrual age (PMA), oxygen exposure and oxygen requirement at 36 weeks PMA. In 2001, the National Institute of Child Health and Human Development (NICHD) workshop proposed the current definition where infants born at less than or equal to 32 weeks GA with 28 days of oxygen exposure get diagnosed with mild, moderate or severe BPD at 36 weeks PMA based on their respiratory support at that time.<xref ref-type="bibr" rid="article-18655.r8">[8]</xref> Table 1 illustrates the definition used for diagnosing and classifying the severity of the disease.</p>
        <p>This definition still has many deficiencies and does not adequately predict respiratory outcomes; hence in 2016, the NICHD workshop on BPD proposed a revision of this definition. The suggested refinement suggests utilizing radiographic confirmation and accounts for the newer modes of non-invasive ventilation.<xref ref-type="bibr" rid="article-18655.r9">[9]</xref> Although this new definition classifies BPD further, it does not address the primary limitation of utilizing the treatment modality as the primary factor defining the disease and its severity.<xref ref-type="bibr" rid="article-18655.r10">[10]</xref></p>
      </sec>
      <sec id="article-18655.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The global aim in the management of infants with BPD is to support them while lung growth occurs, limit further injury to the lungs, optimize lung function and detect complications associated with BPD. The various measures employed in the care of these infants are-</p>
        <list list-type="order">
          <list-item>
            <p>Nutrition: Infants with BPD need an increased amount of energy to promote lung growth and repair. Their nutritional need maybe up to 140 to 150 Kcal/Kg/day and protein intake from 3.5 to 4 g/kg/day.<xref ref-type="bibr" rid="article-18655.r11">[11]</xref> Breast milk is preferable to formula. Commercial milk fortifiers can be used to fortify the mother&#x02019;s milk or donor breast milk to higher calories.<xref ref-type="bibr" rid="article-18655.r12">[12]</xref> Intramuscular supplementation of vitamin A started within a few days of birth and administered three times a week for 4 weeks has been shown to decrease the risk of BPD by 7%.<xref ref-type="bibr" rid="article-18655.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Fluid restriction: Based on the severity of their lung disease, infants are restricted to a total fluid volume of 120 to 150 ml/kg/day. Restriction of fluid intake allows for improved pulmonary function by preventing pulmonary edema and improving gas exchange. Although frequently followed, there is insufficient data to support this practice.<xref ref-type="bibr" rid="article-18655.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Minimize ventilator-associated lung injury: Non-invasive ventilation is the preferred mode of ventilation wherever feasible. If mechanical ventilation is necessary, care should be taken to limit barotrauma and volutrauma. Early extubation has been shown to lower the rates of BPD.<xref ref-type="bibr" rid="article-18655.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Minimize oxygen associated injury: Exposure to hyperoxia is one of the most critical factors in the pathogenesis of BPD. There is significant controversy regarding SpO target ranges. One approach attempts to target SpO of 88-94% with a lower alarm limit of 88% and a higher alarm limit of 96%.<xref ref-type="bibr" rid="article-18655.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Pharmacological interventions:</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Corticosteroids: Systemic corticosteroids have been used in BPD to improve lung function, reduce inflammation and reduce the need for mechanical ventilation. However, concerns about long term neurodevelopmental outcomes have led to recommendations to restrict their use to infants with severe BPD who remain ventilator dependent with high oxygen needs.<xref ref-type="bibr" rid="article-18655.r17">[17]</xref><xref ref-type="bibr" rid="article-18655.r18">[18]</xref> Despite many clinical trials, it is unclear as to which corticosteroid provides the most benefit and at the optimal&#x000a0;dose. Notwithstanding the variable evidence, low dose dexamethasone and hydrocortisone continue to be used in practice in the treatment of BPD.<xref ref-type="bibr" rid="article-18655.r19">[19]</xref> The current data does not demonstrate support for the routine use of inhaled corticosteroids to prevent BPD.<xref ref-type="bibr" rid="article-18655.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Diuretics: Thiazides and loop diuretics are the most commonly used diuretics in the setting to improve short term pulmonary mechanics of BPD. These agents are most commonly used in infants who are ventilator dependent with increasing requirement of positive end-expiratory pressure despite fluid restriction. A systemic review of available literature does not show any improvement in long term clinical outcome in infants with established or developing BPD.<xref ref-type="bibr" rid="article-18655.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Bronchodilators:- administration of beta-2 agonists can decrease airway resistance and improve compliance. However, their routine use is not recommended in BPD as it has not been shown to improve long term outcomes. Their use should be restricted to manage acute episodes of bronchoconstriction in older infants who remain ventilator dependent.<xref ref-type="bibr" rid="article-18655.r22">[22]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18655.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="order">
          <list-item>
            <p>Pulmonary atelectasis</p>
          </list-item>
          <list-item>
            <p>Pneumonia</p>
          </list-item>
          <list-item>
            <p>Pulmonary hypertension</p>
          </list-item>
          <list-item>
            <p>Tracheomalacia</p>
          </list-item>
          <list-item>
            <p>Pulmonary interstitial emphysema</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18655.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>BPD is a chronic illness that persists beyond discharge from the hospital and into adulthood. Infants with BPD have a 50% chance of readmission to the hospital during their first year of life. They have an increased risk of developing reactive airway disease, asthma, emphysema, and RSV bronchiolitis. BPD also affects their growth and neurodevelopmental outcome. VLBW infants with BPD are more likely to have delays in fine and gross motor skills, and language.<xref ref-type="bibr" rid="article-18655.r23">[23]</xref></p>
        <p>Infants with BPD are at high risk for cardiopulmonary sequelae like pulmonary hypertension (PH), cor pulmonale, and systemic hypertension. A recent meta-analysis reported an accumulative estimated prevalence of PH in BPD to be 20% and can be as high as 40% in severe BPD. A newer, prospective study showed that BPD-associated pulmonary hypertension (BPD-PH) affects at least 8 to 25% of extremely low birth weight (birth weight less than 1000g) infants. Retrospective studies demonstrate a 2-year morbidity rate of 26 to 47% in patients with BPD-PH.<xref ref-type="bibr" rid="article-18655.r24">[24]</xref></p>
      </sec>
      <sec id="article-18655.s12" sec-type="Complications">
        <title>Complications</title>
        <p>BPD is one of the most prevalent morbidities associated with prematurity and carries associations with the following complications-</p>
        <list list-type="order">
          <list-item>
            <p>Systemic hypertension</p>
          </list-item>
          <list-item>
            <p>Poor neurodevelopmental outcome</p>
          </list-item>
          <list-item>
            <p>Pulmonary Hypertension</p>
          </list-item>
          <list-item>
            <p>Left ventricular hypertrophy and left ventricular dysfunction</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18655.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Bronchopulmonary dysplasia (BPD) is a severe disease that affects babies who are born early and need to be in the NICU. It&#x000a0;causes breathing problems in babies and occurs because their lungs are not well developed and ready to do the work of breathing. These babies often need to have a breathing tube and are connected to a breathing machine to help them breathe. They may need several medications during their hospital stay to help with this lung disease. Some babies may also require home oxygen and may need to return to the hospital if they develop respiratory infections. Babies with BPD also need more energy and may require extra nutrition.</p>
        <p>Babies who have BPD may develop other problems such as:</p>
        <list list-type="order">
          <list-item>
            <p>Increased blood pressure</p>
          </list-item>
          <list-item>
            <p>Eye and ear problems</p>
          </list-item>
          <list-item>
            <p>Development problems</p>
          </list-item>
          <list-item>
            <p>Heart problems.</p>
          </list-item>
        </list>
        <p>While in the NICU the doctors must be vigilant for these problems. Even after discharge, the baby may require followup for with doctors and developmental specialists.</p>
      </sec>
      <sec id="article-18655.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Optimizing care of infants with BPD requires an interprofessional team approach that includes a neonatologist, nurses, pediatric pulmonologist, respiratory therapist, nutritionist, physical and occupational therapists, social worker and child life specialist. Training of the parent prior to discharge is critical. At the time of transition from hospital to home, adequate discharge planning is essential with setting up follow appointments and making sure parents have all the supplies necessary for taking care of their child.</p>
      </sec>
      <sec id="article-18655.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18655&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18655">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/bronchopulmonary-dysplasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18655">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18655/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18655">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18655.s16">
        <fig id="article-18655.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Definition of BPD "Contributed by Mitali Sahni, MD"</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="BPD__definition" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18655.s17">
        <title>References</title>
        <ref id="article-18655.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Northway</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Rosan</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.</article-title>
            <source>N Engl J Med</source>
            <year>1967</year>
            <month>Feb</month>
            <day>16</day>
            <volume>276</volume>
            <issue>7</issue>
            <fpage>357</fpage>
            <page-range>357-68</page-range>
            <pub-id pub-id-type="pmid">5334613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jobe</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>The new BPD: an arrest of lung development.</article-title>
            <source>Pediatr Res</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>641</fpage>
            <page-range>641-3</page-range>
            <pub-id pub-id-type="pmid">10590017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balany</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2015</year>
            <volume>2</volume>
            <fpage>90</fpage>
            <pub-id pub-id-type="pmid">26734611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of bronchopulmonary dysplasia.</article-title>
            <source>Birth Defects Res A Clin Mol Teratol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>100</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-57</page-range>
            <pub-id pub-id-type="pmid">24639412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Schibler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carlo</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Finer</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Duara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>O'Shea</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Faix</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.</article-title>
            <source>Pediatrics</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>443</fpage>
            <page-range>443-56</page-range>
            <pub-id pub-id-type="pmid">20732945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morty</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in the pathogenesis of BPD.</article-title>
            <source>Semin Perinatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>404</fpage>
            <page-range>404-412</page-range>
            <pub-id pub-id-type="pmid">30384986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coalson</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Pathology of new bronchopulmonary dysplasia.</article-title>
            <source>Semin Neonatol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-81</page-range>
            <pub-id pub-id-type="pmid">12667832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Vohr</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Jobe</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Fanaroff</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Wrage</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>K</given-names>
              </name>
              <collab>National Institutes of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.</article-title>
            <source>Pediatrics</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>116</volume>
            <issue>6</issue>
            <fpage>1353</fpage>
            <page-range>1353-60</page-range>
            <pub-id pub-id-type="pmid">16322158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Jobe</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Koso-Thomas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bancalari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Viscardi</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Hartert</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Kallapur</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Steinhorn</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Konduri</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Thebaud</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Clyman</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Collaco</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Finer</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>TNK</given-names>
              </name>
            </person-group>
            <article-title>Bronchopulmonary Dysplasia: Executive Summary of a Workshop.</article-title>
            <source>J Pediatr</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>197</volume>
            <fpage>300</fpage>
            <page-range>300-308</page-range>
            <pub-id pub-id-type="pmid">29551318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The definition of bronchopulmonary dysplasia: an evolving dilemma.</article-title>
            <source>Pediatr Res</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>586</fpage>
            <page-range>586-588</page-range>
            <pub-id pub-id-type="pmid">30188504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arigliani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spinelli</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Liguoro</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cogo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Nutrition and Lung Growth.</article-title>
            <source>Nutrients</source>
            <year>2018</year>
            <month>Jul</month>
            <day>18</day>
            <volume>10</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">30021997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>McGrath-Morrow</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Collaco</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Impact of breast milk on respiratory outcomes in infants with bronchopulmonary dysplasia.</article-title>
            <source>Pediatr Pulmonol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>313</fpage>
            <page-range>313-318</page-range>
            <pub-id pub-id-type="pmid">30609293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ambalavanan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Tyson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Roane</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carlo</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants.</article-title>
            <source>J Pediatr</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>142</volume>
            <issue>6</issue>
            <fpage>656</fpage>
            <page-range>656-61</page-range>
            <pub-id pub-id-type="pmid">12838194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasha</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>XQ</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Bronchopulmonary dysplasia: Pathogenesis and treatment.</article-title>
            <source>Exp Ther Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>4315</fpage>
            <page-range>4315-4321</page-range>
            <pub-id pub-id-type="pmid">30542380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhandari</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The potential of non-invasive ventilation to decrease BPD.</article-title>
            <source>Semin Perinatol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-14</page-range>
            <pub-id pub-id-type="pmid">23582965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dumpa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Surfactant, steroids and non-invasive ventilation in the prevention of BPD.</article-title>
            <source>Semin Perinatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>444</fpage>
            <page-range>444-452</page-range>
            <pub-id pub-id-type="pmid">30343941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <collab>Committee on Fetus and Newborn</collab>
            <article-title>Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.</article-title>
            <source>Pediatrics</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>330</fpage>
            <page-range>330-8</page-range>
            <pub-id pub-id-type="pmid">11826218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baud</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maury</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lebail</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ramful</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>El Moussawi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nicaise</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zupan-Simunek</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Coursol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beuch&#x000e9;e</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bolot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Andrini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>C</given-names>
              </name>
              <collab>PREMILOC trial study group</collab>
            </person-group>
            <article-title>Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Apr</month>
            <day>30</day>
            <volume>387</volume>
            <issue>10030</issue>
            <fpage>1827</fpage>
            <page-range>1827-36</page-range>
            <pub-id pub-id-type="pmid">26916176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doyle</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>McPhee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carlin</surname>
                <given-names>JB</given-names>
              </name>
              <collab>DART Study Investigators</collab>
            </person-group>
            <article-title>Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.</article-title>
            <source>Pediatrics</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-83</page-range>
            <pub-id pub-id-type="pmid">16396863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Ohlsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Halliday</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <day>04</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD001969</fpage>
            <pub-id pub-id-type="pmid">28052185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brion</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Ambrosio-Perez</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2011</year>
            <month>Sep</month>
            <day>07</day>
            <volume>2011</volume>
            <issue>9</issue>
            <fpage>CD001817</fpage>
            <pub-id pub-id-type="pmid">21901679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sosulski</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abbasi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia.</article-title>
            <source>Pediatr Pulmonol</source>
            <year>1986</year>
            <season>Sep-Oct</season>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>269</fpage>
            <page-range>269-73</page-range>
            <pub-id pub-id-type="pmid">3774383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Neurodevelopmental outcome of bronchopulmonary dysplasia.</article-title>
            <source>Semin Perinatol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>227</fpage>
            <page-range>227-32</page-range>
            <pub-id pub-id-type="pmid">16860163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18655.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhandari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Pitfalls, problems, and progress in bronchopulmonary dysplasia.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>6</issue>
            <fpage>1562</fpage>
            <page-range>1562-73</page-range>
            <pub-id pub-id-type="pmid">19482769</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
